Cargando…
Omarigliptin alleviates cognitive dysfunction in Streptozotocin-induced diabetic mouse
Increasing epidemiological evidence supports the strong association between diabetes mellitus (DM) and cognitive dysfunction. Omarigliptin is a long-acting dipeptidyl peptidase 4 (DPP-4) inhibitor for the treatment of diabetes. However, the effect of Omarigliptin in diabetes-associated cognitive dys...
Autores principales: | Li, Xiaoyan, Yin, Ying, Li, Wenfeng, Li, Shanshan, Zhang, Dandan, Liu, Zehong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161942/ https://www.ncbi.nlm.nih.gov/pubmed/35389830 http://dx.doi.org/10.1080/21655979.2022.2055699 |
Ejemplares similares
-
The effects of Omarigliptin on promoting osteoblastic differentiation
por: Liao, Fake, et al.
Publicado: (2021) -
Abnormal gut microbiota composition contributes to cognitive dysfunction in streptozotocin-induced diabetic mice
por: Yu, Fan, et al.
Publicado: (2019) -
Ergosterol Alleviates Kidney Injury in Streptozotocin-Induced Diabetic Mice
por: Ang, Li, et al.
Publicado: (2015) -
Albiflorin alleviates cognitive dysfunction in STZ-induced rats
por: Ma, Xiaojun, et al.
Publicado: (2021) -
Valsartan alleviates the blood–brain barrier dysfunction in db/db diabetic mice
por: Cai, Longxue, et al.
Publicado: (2021)